Target intelligence / Profile preview

Family with sequence similarity 20 member C (FAM20C) (FAM20C)

Target
FAM20C
Molecular classification
Enzyme (Protein kinase), Secretory pathway kinase, Golgi-associated kinase
01

Overview

Family with sequence similarity 20 member C (FAM20C) is a Golgi-associated serine/threonine protein kinase that phosphorylates secreted proteins containing Ser-x-Glu/pSer motifs as well as other related motifs[1][3][5]. FAM20C is the physiological casein kinase of the secretory pathway, controlling the phosphorylation of hundreds of substrates involved in biomineralization, calcium homeostasis, wound healing, lipid metabolism, and neuropeptide function[1][2][4][7]. Pathogenic variants in FAM20C cause Raine syndrome, a severe, often lethal, osteosclerotic skeletal disorder characterized by abnormal bone formation and systemic complications[2][5]. FAM20C is also implicated in cancer progression—particularly glioma and breast cancer—where it promotes tumor invasion and metastasis[4][6]. Experimental inhibitors of FAM20C are in development as potential anti-cancer therapeutics. Due to its broad tissue expression and substrate scope, FAM20C is central to multiple physiological systems but also presents risks for broad off-target effects when used as a therapeutic target[1][4][6][7].

Other names
Golgi casein kinaseGolgi-enriched fraction casein kinase (GEF-CK)Dentin matrix protein 4 (DMP4)Extracellular serine/threonine protein kinase FAM20CDMP-4G-CKRNSfamily with sequence similarity 20, member C
02

Mechanism of action

Inhibition of FAM20C kinase activity (reduces phosphorylation of secreted proteins, can block tumor invasion and growth in preclinical models); Modulation of calcium and phosphate homeostasis by altering phosphorylation status of biomineralization proteins

03

Biological functions

Protein phosphorylation of secreted proteinsBiomineralization (bone and tooth mineralization)Regulation of calcium homeostasisRegulation of lipid and cholesterol metabolismPhosphorylation of neuropeptides and hormone precursorsRegulation of extracellular matrix interactionsModulation of cell adhesion, migration, and apoptosisRegulation of ER and sarcoplasmic reticulum proteostasis
04

Disease associations

Cancer (notably glioma, breast cancer, and other aggressive tumors)Bone disorders (Raine syndrome, osteosclerotic dysplasia)Cardiovascular disease (vascular calcification, arrhythmia)Metabolic disorders (cholesterol/lipid homeostasis)Neurological diseases (possible in neurodegeneration, cognitive impairment)Other congenital and systemic diseases linked to FAM20C deficiency
05

Safety considerations

Potential off-target effects due to broad substrate specificity (affecting bone, cardiovascular, and neural tissues)Disturbance of mineralization processes (risk of bone or dental defects)Unknown long-term effects on proteostasis and calcium homeostasis[1][5]
06

Interacting drugs

Candidate FAM20C inhibitors (no widely approved drugs as of June 2024, but small molecule inhibitors in development for cancer and metabolic disease)[4][6]
07

Biomarkers

FAM20C expression level (diagnostic/prognostic in lower grade glioma and triple-negative breast cancer)Phosphorylation status of specific secreted proteins (e.g., caseins, osteopontin, DMP1)Mutational analysis in suspected Raine syndrome[2][6]

Beyond the preview

Go deeper on Family with sequence similarity 20 member C (FAM20C) (FAM20C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 20 member C (FAM20C) (FAM20C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call